<DOC>
	<DOC>NCT00600067</DOC>
	<brief_summary>The purpose of the study is to determine the long-term safety and efficacy of VI-0521 (phentermine/topiramate) compared to placebo in providing blood sugar control in Type 2 diabetic adults. Continuation of initial 6 month trial.</brief_summary>
	<brief_title>A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults</brief_title>
	<detailed_description />
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Phentermine</mesh_term>
	<criteria>Have completed the qualifying OB202 trial If females of childbearing potential, subjects must be using adequate contraception Provide written informed consent Be willing and able to comply with scheduled study visits, treatment plan, lab tests and other study procedures Subjects who have developed one or more morbidities during the OB202 trial that would pose a safety concern</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Metabolic Diseases</keyword>
	<keyword>Glucose Metabolism Disorders</keyword>
	<keyword>Glycemic Control</keyword>
</DOC>